Phase hub

Unknown clinical trial failures

Explore 1,716 stopped unknown clinical trials with sponsors, indications, and stop-reason signals.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 54 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials1,716
Likely biological signals54
Shown below100

Dominant stop reasons

OPERATIONAL
895
OTHER/UNKNOWN
762
EFFICACY/FUTILITY
33
SAFETY
21
REGULATORY
5

Notable sponsors

Stanford University
25
The Cleveland Clinic
25
Northwestern University
24
Massachusetts General Hospital
20
Washington University School of Medicine
19

Related phases

Unknown
1,716

Crawlable stopped-trial records

Open Explore

Showing up to 100 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT02225600: The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults

Unknown Borderline Personality Disorder trial by Icahn School of Medicine at Mount Sinai. Stop reason: OPERATIONAL.

Study was halted during COVID pandemic. However, PI is currently reconnecting with a compounding pharmacy to re-establish supply of the oxytocin and updating cost estimates. We are hoping to resume the pilot work with oxytocin once it is clarified.